Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Adding value to the mix

GQG Partners
3:27pm
February 14, 2025
GQQ reported revenue +% and NPAT +53% on pcp to US$431.6m. The result slightly beat expectations across the board, with operating profit delivering ~11% HOH growth to US$303.7m. The flows outlook remains solid at the group level, with acceleration of inflows in the wholesale channel looking set to continue. Recent investment underperformance in the EM strategy could see some outflow risk in the strategy. The dividend payout policy range has changed to 50-95%. The group stated there is no current intention to vary the payout, however this allows the flexibility to build capital for strategic opportunities if required. GQG still has meaningful growth based on the current fund offerings; with longer-term optionality from leveraging the distribution capability (PCS; additional teams). We view the valuation as attractive at ~10x FY25 PE. Add maintained.

Model update and 1H25 result

Northern Star Resources
3:27pm
February 14, 2025
1H25 earnings were solid, driven by a strong gold price with underlying EBITDA exceeding expectations by 3%. 804koz of gold was sold at an average realised price of A$3,562/oz, with an AISC of A$2,105/oz. Balance sheet is strong, with A$265m in net cash and a record interim dividend of A$0.25 per share beating Morgans' forecast of A$0.21 per share. We have updated our model to incorporate changes in spot gold price (US$2,850, previously US$2,600).

Luxury lead growth strategy delivers

Treasury Wine Estates
3:27pm
February 13, 2025
TWE’s 1H25 result was strong, albeit it was cycling a weak pcp and Penfolds benefited from China’s reopening and Treasury Americas (TA) from the acquisition of DAOU. Pleasingly, its two Luxury portfolios grew strongly while its much smaller and low margin Treasury Premium Brands (TPB) continues to disappoint. FY25 EBITS guidance was revised by 1.9% at the mid-point due to TPB’s underperformance. DAOU’s synergy target was materially upgraded. TWE’s targets for both of its Luxury wine businesses over the next few years, if delivered, will underpin double digit earnings growth out to FY27. While not without risk given industry and macro headwinds, TWE’s trading multiples look particularly attractive to us and we maintain an Add rating.

Further changes to portfolio coming

South32
3:27pm
February 13, 2025
Healthy 1H25 earnings, with S32 posting a 3% underlying NPAT beat. S32 plans to divest its interest in Cerro Matoso (nickel), while still interested adding more zinc and copper to its portfolio (M&A). Having virtually wiped away its net debt, its ROIC recovering to 9% in 1H, and expecting a working capital unwind in 2H, we see S32 as in a strong position to pursue these plans and possibly surprising on its final dividend. Recovery work at Australian manganese is progressing to plan, with S32 still expecting sales to resume in 4Q’FY25. We maintain an ADD rating on S32, expecting the stock to perform strongly against a backdrop of steadying global/China growth. A$4.30 target price (unchanged).

Strong markets buffering against softer listings

Aust Securities Exchange
3:27pm
February 13, 2025
ASX’s 1H25 result, whilst broadly per consensus revenue expectations (~A$542m, +~6% on pcp), was a ~3% beat at NPAT (~A$254m, +~10% on pcp). A strong ‘Markets’ performance (‘Futures and OTC’ and ‘Cash market’ trading) as well as a solid net interest income outcome (+~9% on pcp) helped offset a flat Listings outcome. FY25 guidance was unchanged. We make marginal changes to our FY25-FY27 EPS estimates (-0.5%-+1%). Our price target increases marginally to A$67.20 on a roll-forward. Hold maintained.

Demand recovery remains uncertain

Orora
3:27pm
February 13, 2025
ORA's 1H25 result was below expectations with management’s guidance for 2H25 also weaker than anticipated. While market conditions remain challenging globally and destocking in Saverglass continues, management said there were some encouraging signs of improved order intake which could benefit volumes in 4Q25. We decrease FY25-27F underlying EBIT by between 12-14%. Our target price falls to $2.15 (from $2.60) following updates to earnings forecasts. In our view, the share price in the near term should be supported by the buyback and the potential for private equity interest to return. However, operationally we think the demand environment remains soft and there is uncertainty on when volumes will recover. Trading on 17.2x FY26F PE and 4.5% yield, we see ORA as fully valued and retain our Hold rating.

Tougher outlook or being conservative?

Insurance Australia Group
3:27pm
February 13, 2025
IAG’s 1H25 reported NPAT (A$778m) was 11% above consensus (A$699m), driven by natural perils costs being A$215m below allowances. We think a combination of IAG talking to moderating premium rate increases, and the company being somewhat cagey on the Underlying Insurance Margin trajectory in 2H25, lead to the share price falling ~9% on the day. On the latter, we think there is sound reasons to think the UIM expands in 2H25. We lift our IAG FY25F EPS by 10% on lower 1H25 hazard claims than estimated, but reduce FY26F/FY27F EPS by 1%-2% on more conservative top-line growth estimates. Our PT falls to A$8.02 (previously A$8.65). IAG management has delivered strongly in recent times, but we see the stock as trading closer to fair value on 20x FY26F PE, and we maintain our Hold call.

It’s a lot brighter on the other side

Alliance Aviation Services
3:27pm
February 13, 2025
The 1H25 was another solid half of delivery for AQZ as it continues to execute its E190 fleet expansion. All key metrics across P&L/BS/CF either beat or were largely in line with MorgansF (despite significant disruptions). Whilst flight hours, revenue and EBITDA grew strongly, weaker NPBT growth reflected higher net interest given AQZ’s rising net debt levels to fund the purchase of its E190s. AQZ is now past peak leverage and capex. Over the next 18 months we see multiple catalysts/tailwinds for the stock being: 1) improving FCF outflows over 2H25/FY26; 2) return to positive FCF in the 2H26 and significant FCF generation from FY27; 3) balance sheet de-levering; 4) net debt declining; 5) resumption of dividends; and 6) announcements of significant Aviation Services transactions.

Closely watched

Monadelphous Group
3:27pm
February 13, 2025
The 1H25 headline result should contain limited surprises given MND has pre-released operating NPAT of $33-36m (+10-20% YoY). What has driven the material growth, however, should draw most of the attention, as this will have important implications for 2H. Given the revenue guidance in November for 1H to be up slightly on the pcp, the margin expansion looks unusually high, which indicates that the business may have benefited from either (or both) an abnormal amount of profit on sales during the period (as was the case in 2H24) or a material de-mobilisation payment relating to Albemarle’s Kemerton project. Forecasting for 2H is hazardous, though, at this stage, without more information, we fade the margin. We are now forecasting FY25 EBITDA of $143m. If margin expansion has been purely organic, this trend would be tremendously supportive for the stock and our 2H25 and FY26-27 forecasts are likely to be too conservative. This result will be closely watched. Target price moves to $14.80 (from $14.28).

Choo choo

Pro Medicus
3:27pm
February 13, 2025
The freight train which is PME continues to skip all stations on its march toward record financial results, new contracts, and subsequent market valuation. To put this into perspective, over the last 7 months PME has signed almost A$500m in new contracts which is more than it has added over the prior 3 years combined. Once live, these new contracts will add a further A$56m of high-margin minimum contracted revenues over 7 plus years. This works out to add ~35% of FY24’s revenue base. The machine continues to steam ahead. So no surprises that the result itself was another record and whilst key forward metrics continue to look strong, it remains hard to justify the valuation. Notwithstanding, consolidation in the sector continues to present long-term benefits to PME and we have opted to roll through a marginally higher long-term growth rate as a proxy for potential further tailwinds. Our target price increases to A$250 p/s but retain a Hold recommendation.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more